VNN2-expressing circulating monocytes exhibit unique functional characteristics and are decreased in patients with primary Sjögren's syndrome.

Ayibaota BahabayiXiayidan AlimuGuochong WangYiming GaoYang ChenJunjie ZhaoXinran LianQi LiZiqi XiongZhonghui ZhangPingzhang WangChen Liu

Published in: Journal of autoimmunity (2024)

Monocytes expressing cell surface VNN2 are significantly reduced in pSS patients. This suggests a potential role for VNN2 in pSS development and its potential use as a diagnostic marker for pSS.

Keyphrases

cell surface
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
peripheral blood
rheumatoid arthritis